arrow
刘钢 封面图

刘钢 (Gang Liu)

university of technology sydney高级实验师
H指数:50
被引数:1.9万

个人简介

"刘钢,博士研究生,高级实验师、硕士生导师。邮箱:1519816612@qq.com。通讯地址:石河子大学医学院杏三楼办公室A-105号\n2.科研学术工作经历与教育背景\n2004.9-2007.6 石河子大学临床兽医学专业,硕士学位\n2015.9-2022.6 石河子大学动物健康养殖与安全生产专业,博士学位\n2008.8-至今 就职于石河子大学医学院基础医学系人体解剖教研室"

教育背景

  • 2015.09 – 2022.06

    石河子大学 博士学位 动物健康养殖与安全生产专业

  • 2004.09 – 2007.06

    石河子大学 硕士学位 临床兽医学专业

工作经历

  • 2008.08 – 至今

    石河子大学医学院基础医学系人体解剖教研室

    高级实验师

荣誉奖项

  1. 兵团科技进步一等奖(2019)
Vitronectin metabolically programs profibrotic macrophages in 3D cultures and idiopathic pulmonary fibrosis

纤维连接蛋白在三维培养中代谢性地调控促纤维化巨噬细胞,并影响特发性肺纤维化

2026-07-150
OA
Vitronectin regulates lung tissue remodeling and emphysema in chronic obstructive pulmonary disease

Vitronectin 调节慢性阻塞性肺疾病中的肺组织重塑和肺气肿

2025-01-011
PRE
Increased therapeutic index of muzastotug (ADG126), a masked anti-CTLA-4 antibody, in combination with pembrolizumab (pembro) enables significant clinical benefits and supports further clinical development in patients with metastatic MSS CRC

未修饰的抗-CTLA-4抗体muzastotug(ADG126)与pembrolizumab(pembro)联合应用,其治疗指数的增加可实现显著的临床获益,并支持其在转移性MSS结直肠癌患者中进一步的临床开发。

2024-09-010
PRE
Pre-COVID life expectancy, mortality, and burden of diseases for adults 70 years and older in Australia: a systematic analysis for the Global Burden of Disease 2019 Study

澳大利亚70岁及以上成年人的预期寿命、死亡率和疾病负担: 全球疾病负担2019研究的系统分析

2024-06-010
OAAI
SDH, a novel diarylheptane compound, alleviates dextran sulfate sodium (DSS)-induced colitis by reducing Th1/Th2/Th17 induction and regulating the gut microbiota in mice

SDH是一种新型二芳基庚烷化合物,通过减少小鼠Th1/Th2/Th17诱导和调节肠道菌群来缓解葡聚糖硫酸钠 (DSS) 诱导的结肠炎

2024-06-010
PRE
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021

1990至2021 204个国家和地区以及811个地方的371疾病和伤害的全球发病率,患病率,残疾寿命 (YLDs),残疾调整寿命 (DALYs) 和健康预期寿命 (HALE): 全球疾病负担研究2021的系统分析

LANCET
IF88.5
2024-05-01285
OAAI
Global fertility in 204 countries and territories, 1950-2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021

1950至2021 204个国家和地区的全球生育率,预测到2100: 全球疾病负担研究2021的综合人口分析

LANCET
IF88.5
2024-05-0143
OAAI
Burden of disease scenarios for 204 countries and territories, 2022-2050: a forecasting analysis for the Global Burden of Disease Study 2021

2022至2050 204个国家和地区的疾病负担情景: 全球疾病负担研究2021的预测分析

LANCET
IF88.5
2024-05-0179
OAAI
TLR7 promotes smoke-induced experimental lung damage through the activity of mast cell tryptase

TLR7通过肥大细胞类胰蛋白酶活性促进烟雾诱导的实验性肺损伤

2023-11-145
OAAI